Newborn screening for primary immunodeficiencies: beyond SCID and XLA

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Primary immunodeficiencies (PID) comprise over 250 distinct conditions.
• Early diagnosis and treatment of PID are vital to prevent severe infections and organ damage.
• Neonatal screening assays have emerged for detecting T and B lymphocyte deficiencies.

Purpose of the Study:

• To review the role of neonatal screening in identifying primary immunodeficiencies.
• To discuss the implications of reduced T and B cells in newborns beyond SCID and XLA.
• To highlight the need for advanced diagnostic platforms for PID classification.

Main Methods:

• Review of current literature on neonatal screening for PID.
• Analysis of diagnostic approaches for T and B cell deficiencies.
• Discussion of emerging technical platforms for PID identification.

Main Results:

• Neonatal screening effectively identifies severe combined immunodeficiencies (SCID) and X-linked agammaglobulinemia (XLA).
• Reduced T and B cell counts in newborns can indicate various other forms of PID.
• Supplemental investigations and new platforms are necessary to classify abnormal screening results.

Conclusions:

• Neonatal screening is a valuable tool for early PID detection.
• Abnormal screening results necessitate further comprehensive diagnostic workups.
• Advancements in technology are crucial for accurate PID classification and management.